Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

Istituto Clinico Humanitas, Rozzano, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:4City/State/Province:Rozzano
Treatments:ChemotherapyHospital:Istituto Clinico Humanitas
Drugs:Journal:Link
Date:Apr 2011

Description:

Patients:
This study involved 31 malignant pleural mesothelioma patients who had received prior treatment. The median age of the group was 65 years and 68% were male.

Treatment:
Patients were given a combination of the chemotherapy agents pemetrexed and a platinum compound (carboplatin or cisplatin, depending on the patient’s prior treatment).

Toxicities:
The most severe adverse events reported were grade 4 hematological toxicities, including one case of febrile neutropenia.

Results:
The median overall survival in this study was 10.5 months.

Correspondence: Dr. Giovanni Ceresoli; email: [email protected]



Back